495-85-2,MFCD21364778
Catalog No.:AA00DA1Z

495-85-2 | 2H-Pyran-2-one,6-[(1E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$79.00   $55.00
- +
5mg
≥98%
in stock  
$263.00   $184.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DA1Z
Chemical Name:
2H-Pyran-2-one,6-[(1E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)-
CAS Number:
495-85-2
Molecular Formula:
C15H14O5
Molecular Weight:
274.2687
MDL Number:
MFCD21364778
SMILES:
COC1=CC(=O)OC(C1)C=Cc1ccc2c(c1)OCO2
NSC Number:
112158
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
428  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.4  

Literature

Title: Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.

Journal: Redox biology 20170801

Title: Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Journal: Bioorganic & medicinal chemistry 20121115

Title: Kavalactone metabolism in rat liver microsomes.

Journal: Phytotherapy research : PTR 20120701

Title: Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20111201

Title: Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro.

Journal: Phytotherapy research : PTR 20110301

Title: Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.

Journal: PloS one 20110101

Title: Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.

Journal: Bioorganic & medicinal chemistry letters 20091001

Title: High-performance liquid chromatography assays for desmethoxyyangonin, methysticin, kavain and their microsomal metabolites.

Journal: Biomedical chromatography : BMC 20090101

Title: Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.

Journal: International journal of toxicology 20090101

Title: Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.

Journal: Journal of natural medicines 20080401

Title: Permeability studies of Kavalactones using a Caco-2 cell monolayer model.

Journal: Journal of clinical pharmacy and therapeutics 20070601

Title: Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).

Journal: Journal of agricultural and food chemistry 20060208

Title: Kavalactones fail to inhibit alcohol dehydrogenase in vitro.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20060201

Title: Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation.

Journal: Analytical chemistry 20051101

Title: Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20051001

Title: Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.

Journal: Journal of AOAC International 20050101

Title: Superheated water chromatography-nuclear magnetic resonance spectroscopy of kava lactones.

Journal: Phytochemical analysis : PCA 20050101

Title: Kava does not display metabolic toxicity in a homogeneous cellular assay.

Journal: Planta medica 20040401

Title: Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20040101

Title: Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).

Journal: Planta medica 20021201

Title: Interaction of various Piper methysticum cultivars with CNS receptors in vitro.

Journal: Planta medica 20010601

Title: Shoujun Chen, et al. Methods of inhibiting osteoclast activity. US20030229137A1.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 495-85-2
Tags:495-85-2 Molecular Formula|495-85-2 MDL|495-85-2 SMILES|495-85-2 2H-Pyran-2-one,6-[(1E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)-
Catalog No.: AA00DA1Z
495-85-2,MFCD21364778
495-85-2 | 2H-Pyran-2-one,6-[(1E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)-
Pack Size: 1mg
Purity: ≥98%
in stock
$79.00 $55.00
Pack Size: 5mg
Purity: ≥98%
in stock
$263.00 $184.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DA1Z
Chemical Name: 2H-Pyran-2-one,6-[(1E)-2-(1,3-benzodioxol-5-yl)ethenyl]-5,6-dihydro-4-methoxy-, (6R)-
CAS Number: 495-85-2
Molecular Formula: C15H14O5
Molecular Weight: 274.2687
MDL Number: MFCD21364778
SMILES: COC1=CC(=O)OC(C1)C=Cc1ccc2c(c1)OCO2
NSC Number: 112158
Properties
Form: Solid  
Complexity: 428  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 20  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.4  
Literature fold

Title: Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.

Journal: Redox biology20170801

Title: Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Journal: Bioorganic & medicinal chemistry20121115

Title: Kavalactone metabolism in rat liver microsomes.

Journal: Phytotherapy research : PTR20120701

Title: Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20111201

Title: Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro.

Journal: Phytotherapy research : PTR20110301

Title: Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.

Journal: PloS one20110101

Title: Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.

Journal: Bioorganic & medicinal chemistry letters20091001

Title: High-performance liquid chromatography assays for desmethoxyyangonin, methysticin, kavain and their microsomal metabolites.

Journal: Biomedical chromatography : BMC20090101

Title: Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.

Journal: International journal of toxicology20090101

Title: Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.

Journal: Journal of natural medicines20080401

Title: Permeability studies of Kavalactones using a Caco-2 cell monolayer model.

Journal: Journal of clinical pharmacy and therapeutics20070601

Title: Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).

Journal: Journal of agricultural and food chemistry20060208

Title: Kavalactones fail to inhibit alcohol dehydrogenase in vitro.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology20060201

Title: Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation.

Journal: Analytical chemistry20051101

Title: Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.

Journal: Drug metabolism and disposition: the biological fate of chemicals20051001

Title: Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.

Journal: Journal of AOAC International20050101

Title: Superheated water chromatography-nuclear magnetic resonance spectroscopy of kava lactones.

Journal: Phytochemical analysis : PCA20050101

Title: Kava does not display metabolic toxicity in a homogeneous cellular assay.

Journal: Planta medica20040401

Title: Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology20040101

Title: Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).

Journal: Planta medica20021201

Title: Interaction of various Piper methysticum cultivars with CNS receptors in vitro.

Journal: Planta medica20010601

Title: Shoujun Chen, et al. Methods of inhibiting osteoclast activity. US20030229137A1.

Building Blocks More >
49843-98-3
49843-98-3
6-Chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide
AA00DA7U | MFCD03009471
433684-22-1
433684-22-1
5-Bromo-2-(isopropylthio)pyrimidine
AA00DAAV | MFCD13188494
55487-63-3
55487-63-3
4-PREGNEN-21-OL-3,20-DIONE-2,2,4,6,6,17ALPHA,21,21-D8
AA00DAHU | MFCD06658587
54754-58-4
54754-58-4
2-(5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl)aniline
AA00DAOH | MFCD07790308
519016-83-2
519016-83-2
2-Amino-4-biphenyl-4-ylthiophene-3-carbonitrile
AA00DARY | MFCD02244583
5617-69-6
5617-69-6
3-Azabicyclo[3.1.0]hexane-2,4-dione
AA00DAYV | MFCD00187526
508233-74-7
508233-74-7
1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine
AA00DB50 | MFCD22380814
55919-47-6
55919-47-6
Ethyl 2-bromo-3-oxo-3-phenylpropanoate
AA00DB9D | MFCD08444026
483967-52-8
483967-52-8
N-(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)-N-PROPYLAMINE HYDROCHLORIDE
AA00DBE6 | MFCD07286701
529-65-7
529-65-7
N-Ethylacetanilide
AA00DBK6 | MFCD00026709
Submit
© 2017 AA BLOCKS, INC. All rights reserved.